Related Experiment Video

Updated: Dec 21, 2025

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.5K

Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy

Atsushi Suzuki1, Satoshi Kakugawa2, Masafumi Miyoshi2

  • 1Bristol-Myers Squibb K.K., Shinjuku, Tokyo, Japan. atsushi.suzuki@bms.com.

Leukemia
|May 14, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.5K

Related Concept Videos